CHESS: Human and Computer Mentors for Prostate Cancer Patients - Full Text View

Purpose

The aims include:

To measure the effect of the three study conditions on Quality of Life (QOL).
- CHESS and Cancer Information Mentor will not differ initially (6 weeks) or late in treatment (6 months) in QOL
- CHESS +Cancer Information Mentor will have the largest impact on QOL (initially and late in treatment) and will be significantly better than either CHESS or Cancer Information Mentor alone.
To measure potential intervening or mediating processes, so that we can determine how CHESS and the Cancer Information Mentor produce associated QOL benefits.
To conduct exploratory use analyses examining which types of CHESS content, sequential patterns of content use, or other characteristics of use behavior are associated with greater pretest-posttest improvements in QOL.
To conduct a secondary analysis exploring whether men whose partners have actively used CHESS do better than those whose partners did not use CHESS.

Condition	Intervention
Prostate Cancer	Behavioral: CHESS System Behavioral: Cancer Information Mentor

MedlinePlus related topics:

Cancer Prostate Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Supportive Care, Randomized, Single Blind (Subject), Parallel Assignment, Efficacy Study

Official Title:	CHESS: Human and Computer Mentors for Prostate Cancer Patients

Further study details as provided by M.D. Anderson Cancer Center:

Primary Outcome Measures:

The goal of this research study is to try to find an effective way to provide information, social support, and skill-building tools to men with prostate cancer. [ Time Frame: 3 Years ] [ Designated as safety issue: No ]

Estimated Enrollment:	654
Study Start Date:	July 2007
Estimated Primary Completion Date:	July 2010 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
1: Experimental CHESS System	Behavioral: CHESS System Internet-based computer program for 6 months.
2: Experimental Cancer Information Mentor	Behavioral: Cancer Information Mentor Phone calls to the patient for 6 months.
3: Experimental CHESS System + Cancer Information Mentor	Behavioral: CHESS System Internet-based computer program for 6 months. Behavioral: Cancer Information Mentor Phone calls to the patient for 6 months.

Show Detailed Description

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Inclusion:

Being within 9 weeks of a primary diagnosis of Stage 1 or Stage 2 prostate cancer
Being 18 years of age or older
Being able to read and write English at the 6th grade level (as shown by an ability to understand the informed consent)

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00516256

Contacts


Contact: Cindy Carmack Taylor, PhD	713-745-3582

Locations


United States, Connecticut
	Hartford Hospital	Recruiting
	Hartford, Connecticut, United States, 06102

United States, Texas
	U.T.M.D. Anderson Cancer Center	Recruiting
	Houston, Texas, United States, 77030
	Principal Investigator: Cindy Carmack Taylor, PhD

United States, Wisconsin
	University of Wisconsin Comprehensive Cancer Center	Recruiting
	Madison, Wisconsin, United States, 53792

Sponsors and Collaborators

M.D. Anderson Cancer Center

National Cancer Institute (NCI)

Investigators


Principal Investigator:	Cindy Carmack Taylor, PhD	U.T.M.D. Anderson Cancer Center

More Information

The University of Texas M.D.Anderson Cancer Center This link exits the ClinicalTrials.gov site

Responsible Party:	U.T.M.D. Anderson Cancer Center ( Cindy Carmack Taylor, PhD/Assistant Professor )
Study ID Numbers:	2007-0254
First Received:	August 14, 2007
Last Updated:	October 2, 2008
ClinicalTrials.gov Identifier:	NCT00516256
Health Authority:	United States: Institutional Review Board

Keywords provided by M.D. Anderson Cancer Center:

Prostate Cancer

Quality of Life

Cancer Information Mentor

CHESS

Study placed in the following topic categories:

Prostatic Diseases

Genital Neoplasms, Male

Quality of Life

Urogenital Neoplasms

Genital Diseases, Male

Prostatic Neoplasms

Additional relevant MeSH terms:

Neoplasms

Neoplasms by Site

ClinicalTrials.gov processed this record on October 07, 2008

Sponsors and Collaborators:	M.D. Anderson Cancer Center National Cancer Institute (NCI)
Information provided by:	M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:	NCT00516256